Analyst Ratings for Blueprint Medicines (BPMC) [Neutrals]

BPMC Rating Summary

BPMC Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BPMC
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $118.42 (+8.2%) * Over Last 12-Mos
Rating Score: 6.8 / 10   Percentile Rank: 71%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/31/2021 Credit Suisse Brad Canino New Coverage Neutral
(N/A)
100.00
(N/A)
92.01
(109.47)
18.98% Details
12/3/2020 Stifel Konstantinos Aprilakis New Coverage Hold
(N/A)
110.00
(N/A)
105.65
(109.47)
3.62% Details
Like BPMC Ratings? Also take a look at IMV, SYRS, DCPH

BPMC Ratings News